CompoAtlas

HEPAFAR (R) Fibers

Food supplement declared in France, declaration No 2023-1-1344, decision dated 26 January 2023

HEPAFAR (R) Fibers (sensilab) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.

Brand
sensilab
Food business operator placing the product on the market
SENSILAB Ltd.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
1 sachet (9 g)
Directions for use
Dissoudre 1 sachet dans 250 ml d’eau. Remuer soigneusement pour dissoudre les éventuels grumeaux. Bo
Not recommended for (according to the manufacturer)
Femmes enceintes, Enfants (de moins de 10 ans)

Declaration 191558, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Acacia seyal DelileGommeExtrait sec aqueux7,100 mg
Cichorium intybus L.RacineExtrait sec aqueux1,000 mg
Rosmarinus officinalis L.FeuilleExtrait sec aqueux500 mg

Additives

E330, E955

Other ingredients

poudre de citron

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Avertissiments: Si vous êtes hypersensible ou allergique à l’un des ingrédients de ce produit ou utilisez des médicaments, consultez votre médecin avant utilisation. Ce produit est déconseillé aux femmes enceintes et allaitantes. Déconseillé aux enfants de moins de 10 ans. Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas être utilisés en remplacement d’une alimentation équilibrée et variée et d’un mode de vie sain. Une alimentation variée et équilibrée et un mode de vie sain sont importants. Tenir hors de portée des jeunes enfants

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : sensilab

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line